Reshma Kewalramani, the Mumbai-born CEO of Vertex Pharmaceuticals, secures a spot on Fortune’s 2025 list of the 100 Most Powerful People in Business, ranking at 62. As the first Indian-origin woman to lead a major US biotech firm, her leadership has propelled Vertex to a $110 billion valuation, marked by innovations like the FDA-approved non-opioid pain treatment, Journavx.
